-
Once the details are ironed out, health care reform will offer great opportunities for case managers in a variety of settings, says Margaret Leonard, MS, RN-B, C, FNP, senior vice president for clinical services at Hudson Health Plan and outgoing president of the Case Management Society of America (CMSA).
-
Assistive technology can make life better for everyone and help people live independently in a safe environment, whether they have a catastrophic illness or injury or are elderly with cognitive and/or vision issues, says Hunter Ramseur, MEd, LPC, CDMS, ATP, principal of Atlanta-based Assistive Technology Consulting LLC.
-
-
-
In this issue: Fractures and bisphosphonate therapy, warfarin anticoagulation and influenza vaccine and cotrimoxazole, antiplatelet therapy with clopidogrel and aspirin, FDA Actions.
-
The primary objective of this retrospective study was to estimate the incidence of genetic counseling referral for ovarian cancer patients who were at high risk for carrying a mutation in BRCA1 or BRCA2.
-
Depot medroxyprogesterone acetate (DMPA) is a highly effective progestin-only contraceptive that is widely used by adolescents. DMPA is also associated with suppression of ovarian production of estradiol, and with a decrease in bone density in some users.
-
The management of a patient with suspected fetal macrosomia remains an enigma. Not being able to come up with a consistent plan of management for macrosomia is compounded by our inability to reliably predict it.
-
This is a small U.S.-based clinical trial of 23 adolescent women (ages 14-18) randomized to levonorgestrel-releasing vs Copper T intrauterine device (IUD).
-
This story is the first part of a two-part series on improving care of high-risk youth enrolled in Medicaid. This month, we cover the challenges of this population and new approaches being used. Next month, we examine the impact of improved quality on subsequent contacts with the juvenile justice system.